AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3070032
Drug: Verapamil (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (doses of 40 to 120 mg, twice daily for six weeks)
Trial: 28243132
Drug: SQ HDM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ HDM SLIT-tablet in addition to allergy pharmacotherapy
Trial: 28243132
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus allergy pharmacotherapy
Trial: 28822510
Drug: 80-mg atorvastatin
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80-mg atorvastatin
Trial: 28822510
Drug: 10-mg atorvastatin
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg atorvastatin
Trial: 16715326
Drug: Constant flow
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant flow insufflation of oxygen (CFIO) at a flow rate of 15 l/min
Trial: 8238158
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral tocolytic (Control)
Trial: 2930998
Drug: Zimeldine, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimeldine, 100 mg b.i.d.
Trial: 2930998
Drug: Maprotiline, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline, 75 mg b.i.d.
Trial: 27497358
Drug: Metal drug-eluting
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metal drug-eluting stent (DES)
Trial: 8237933
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg bid
Trial: 8237933
Drug: Clarithromycin 1000
RxNorm normalized name: clarithromycin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 1000 mg bid
Trial: 8237933
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg qid
Trial: 3535491
Drug: Clotrimazole 10
RxNorm normalized name: clotrimazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole 10 mg troches, three times per day
Trial: 20358155
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg once daily for eight weeks
Trial: 20358155
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg once daily for eight weeks
Trial: 20358155
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of enalapril 10 mg and losartan 50 mg daily for eight weeks
Trial: 17016955
Drug: Anthelmintic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthelmintic therapy
Trial: 10477530
Drug: Candesartan (4,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (4, 8, or 16 mg)
Trial: 10477530
Drug: Candesartan (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (4 or 8 mg) plus 20 mg of enalapril
Trial: 1769411
Drug: Chemoimmunotherapy (bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoimmunotherapy (bacillus Calmette‐Guérin + chemotherapy)
Trial: 1769411
Drug: Immunotherapy (bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (bacillus Calmette‐Guérin alone)
Trial: 1769411
Drug: Immunotherapy (specifically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy (specifically for lower limb malignant melanoma)
Trial: 6280621
Drug: Unrefined diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unrefined diet (whole foods, 60 g/day dietary fibre)
Trial: 6280621
Drug: Refined diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined diet (processed foods, 20 g/day dietary fibre)
Trial: 11586056
Drug: Glucose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (50 mg)
Trial: 7768076
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of dofetilide (0.5 mg over 30 minutes)
Trial: 7768076
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of dofetilide (0.5 mg)
Trial: 7768076
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of dofetilide (0.5 mg)
Trial: 496237
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine mixed with dextran 40 solution
Trial: 31841570
Drug: Weekly religious
RxNorm normalized name: red delicious apple allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly religious activities
Trial: 28299455
Drug: Palmitoylethanolamide (PEA)
RxNorm normalized name: Palmitoylethanolamide
DrugBank: Palmidrol (DB14043)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palmitoylethanolamide (PEA) 300 mg twice a day for 60 days
Trial: 26428224
Drug: Gastrografin in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrografin in addition to conservative treatment
Trial: 22169269
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (74 Gy in 37 fractions of 2 Gy)
Trial: 22169269
Drug: Hypofractionated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypofractionated treatment (60 Gy in 20 fractions of 3 Gy)
Trial: 22169269
Drug: Hypofractionated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypofractionated treatment (57 Gy in 19 fractions of 3 Gy)
Trial: 21058472
Drug: Needling therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needling therapy (local and distal points and points selection according to the differentiation)
Trial: 21058472
Drug: Auricular electroacupuncture
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular electroacupuncture therapy
Trial: 17047932
Drug: MDMA 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA 1.5 mg/kg with Fluoxetine 20 mg
Trial: 16143048
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg orally
Trial: 16143048
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg rectally
Trial: 16143048
Drug: 35 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg/kg rectally
Trial: 16143048
Drug: Rectal high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal high-dose (35 mg/kg)
Trial: 12490213
Drug: Rhizophora mangle
RxNorm normalized name: CATH,THORACIC RT ANGLE 28FR K#573048
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhizophora mangle aqueous bark extract (twice a day)
Trial: 12490213
Drug: mercurocrome (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mercurocrome (twice a day)
Trial: 9009112
Drug: Cholecystokinin octapeptide
RxNorm normalized name: Cholecystokinin C-terminal octapeptide
DrugBank: Sincalide (DB09142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cholecystokinin octapeptide (CCK-OP) 30 ng/kg stat and 60 ng/kg/hr by infusion
Trial: 9009112
Drug: Atropine 0.01
RxNorm normalized name: atropine 0.0194 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 0.01 mg/kg stat and 0.01 mg/kg/hr by infusion
Trial: 3107289
Drug: Thyrotropic releasing
RxNorm normalized name: Thyrotropic releasing hormone
DrugBank: Protirelin (DB09421)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Thyrotropic releasing hormone (TRH)
Trial: 26879827
Drug: Pitolisant 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitolisant 200 mg
Trial: 26879827
Drug: Pitolisant 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitolisant 240 mg
Trial: 26879827
Drug: Pitolisant 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitolisant 120 mg
Trial: 26879827
Drug: SAD study
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SAD study at 240 mg
Trial: 26879827
Drug: TQT study
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TQT study at 120 mg
Trial: 12384852
Drug: Atovaquone/proguanil (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atovaquone/proguanil (4 tablets per day for 3 days)
Trial: 1840344
Drug: Midazolam (0.07
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.07 mg/kg i.v.)
Trial: 1840344
Drug: Diazepam (0.14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.14 mg/kg i.v.)
Trial: 1840344
Drug: Placebo (saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline, 0.07 ml/kg i.v.)
Trial: 7049312
Drug: surgery plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: surgery plus 2000 rad (20 Gy) in 10 equal daily fractions
Trial: 28536741
Drug: Community-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based intervention targeted at treatment adherence
Trial: 22546741
Drug: Medication adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication adherence assessment using the Morisky Medication Adherence Scale
Trial: 22546741
Drug: Patient-related attributes,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-related attributes, drug regimen characteristics, health status, patient-provider interaction
Trial: 11274903
Drug: Trandolapril, 2
RxNorm normalized name: Trandolapril, 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril, 2 mg once daily in the morning
Trial: 9588097
Drug: Tensitone (7.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tensitone (7.5% NaCl in 6% dextran 70, Infusia a.s., CR), administered at a dosage of 4 ml/kg
Trial: 2712981
Drug: Immediate cold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate cold therapy
Trial: 2712981
Drug: Simulated therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simulated therapy (Control)
Trial: 31274603
Drug: Caffeinated energy
RxNorm normalized name: Senergy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated energy drink (160 mg of caffeine)
Trial: 30917863
Drug: Diabetes medication
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes medication adherence assessment using the Morisky Medication Adherence Scale (MMAS-8)
Trial: 31912462
Drug: Filgotinib 100
RxNorm normalized name: Nilotinib
DrugBank: Nilotinib (DB04868)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Filgotinib 100 mg once daily
Trial: 27993829
Drug: Filgotinib 200
RxNorm normalized name: nilotinib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Filgotinib 200 mg daily
Trial: 27993829
Drug: Filgotinib 100
RxNorm normalized name: Nilotinib
DrugBank: Nilotinib (DB04868)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Filgotinib 100 mg daily
Trial: 18443343
Drug: Betamethasone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (4 mg)
Trial: 12874677
Drug: Octreotide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (100 micro g administered as an intravenous bolus)
Trial: 10743822
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release codeine (50 mg every 12 h at baseline, escalated to 159 mg every 12 h at final assessment)
Trial: 9206057
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (n = 344, Group II)
Trial: 2996028
Drug: ACTH 4‐9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACTH 4‐9 analog (ORG 2766) 40 mg
Trial: 30232113
Drug: High-flow heated
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow heated and humidified nasal oxygen (HFHO) therapy
Trial: 27152759
Drug: Prostaglandin E1
RxNorm normalized name: Prostaglandin E1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E1 (PGE1) infusion at 0.25 μg/kg/hour for 96 hours starting 1 hour after portal venous reperfusion
Trial: 22592665
Drug: Aliskiren 150
RxNorm normalized name: aliskiren 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150 mg per day increased to 300 mg per day
Trial: 22592665
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker (CCB) group with amlodipine increased from 7.5 mg to 10 mg per day
Trial: 20348368
Drug: EPA-FFA (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA-FFA (2 g daily for 6 months)
Trial: 1827016
Drug: Sustained-release isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release isradipine (isradipine SR) 5 mg/day
Trial: 1827016
Drug: Sustained-release isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release isradipine (isradipine SR) 10 mg/day
Trial: 6953986
Drug: Daunorubicin (DNR)
RxNorm normalized name: daunorubicin
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daunorubicin (DNR) 45 mg/sq m
Trial: 6953986
Drug: Daunorubicin (DNR)
RxNorm normalized name: daunorubicin
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daunorubicin (DNR) 30 mg/sq m
Trial: 6953986
Drug: Adriamycin (ADM)
RxNorm normalized name: Adriamycin
DrugBank: Doxorubicin (DB00997)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adriamycin (ADM) 30 mg/sq m
Trial: 31479005
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity intervention (9-month curriculum, daily after school)
Trial: 30887570
Drug: β-D-Mannuronic acid
RxNorm normalized name: D-glucuronic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-D-Mannuronic acid (1000 mg/d, 2 capsules orally for 8 weeks)
Trial: 30887570
Drug: β-D-Mannuronic acid
RxNorm normalized name: D-glucuronic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-D-Mannuronic acid therapy
Trial: 21873264
Drug: Infliximab 5
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab 5 mg/kg plus daily glucocorticosteroids
Trial: 21873264
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus daily glucocorticosteroids
Trial: 20008203
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonists (warfarin) for patients with antiphospholipid antibodies and venous thromboembolism
Trial: 20008203
Drug: Aspirin or
RxNorm normalized name: aspirin Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin or warfarin for ischemic stroke
Trial: 20008203
Drug: Prophylactic-dose heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic-dose heparin and aspirin for women with recurrent pregnancy loss
Trial: 20008203
Drug: Antithrombotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombotic therapy in patients with APS-associated thrombocytopenia
Trial: 16355282
Drug: Oral alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alendronate 1 mg/kg/day
Trial: 16355282
Drug: Intravenous pamidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pamidronate 3 mg/kg/4 months
Trial: 15104556
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose therapy (1 mg/day oestradiol‐17 beta with 5 or 10 mg/day dydrogesterone)
Trial: 15104556
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose therapy (2 mg/day oestradiol‐17 beta with 10 or 20 mg/day dydrogesterone)
Trial: 8273241
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg intra-articular morphine
Trial: 8273241
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg intra-articular morphine
Trial: 3304381
Drug: Ketotifen, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketotifen, 1 mg twice daily
Trial: 31741136
Drug: Serum albumin
RxNorm normalized name: Serum albumin
DrugBank: Albumin human (DB00062)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum albumin level (per SD increase of 0.27 g/dL)
Trial: 31741136
Drug: Mendelian randomization
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mendelian randomization analysis (per 1 g/dL increase of albumin)
Trial: 30138665
Drug: Colistin methanesulfonate
RxNorm normalized name: Colistin methanesulfonic acid
DrugBank: Colistimethate (DB01111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colistin methanesulfonate (CMS) 2 MIU + azidothymidine (AZT) 100 mg
Trial: 28235206
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg omega-3 fatty acids from flaxseed oil containing 400 mg α-linolenic acid, twice a day for 12 weeks
Trial: 28235206
Drug: Placebo, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, twice a day for 12 weeks
Trial: 28235206
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg omega-3 fatty acids from flaxseed oil
Trial: 26356057
Drug: Indomethacin per
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indomethacin per rectum and opiate analgesic intramuscularly
Trial: 23924660
Drug: Ribavirin dosage
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ribavirin dosage reduction (n = 249)
Trial: 23924660
Drug: Erythropoietin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin therapy (n = 251)
Trial: 23924660
Drug: Erythropoietin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin therapy (n = 295)
Trial: 23924660
Drug: No erythropoietin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No erythropoietin therapy (n = 392)
Trial: 16557151
Drug: Pflex/LTV (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pflex/LTV (low tidal volume 5-8 mL/kg PBW, PEEP set at Pflex + 2 cm H2O)
Trial: 16557151
Drug: Control (tidal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (tidal volume 9-11 mL/kg PBW, PEEP >= 5 cm H2O)
Trial: 15121371
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and laser treatment
Trial: 11699982
Drug: Antimicrobial agents
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agents
Trial: 11336589
Drug: New antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New antimicrobial compounds
Trial: 9805220
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of red wine
Trial: 9805220
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml of malt whisky
Trial: 8301543
Drug: 0 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg/70 kg morphine
Trial: 8301543
Drug: 2.5 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/70 kg morphine
Trial: 8301543
Drug: 5.0 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5.0 mg/70 kg morphine
Trial: 8301543
Drug: 10 mg/70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/70 kg morphine
Trial: 2899239
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (28 mg)
Trial: 2899239
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (14 mg)
Trial: 2899239
Drug: Oral frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral frusemide (20 mg)
Trial: 29276227
Drug: Constant Current
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant Current (CC) system
Trial: 18297290
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A (BTX-A) injections at different doses
Trial: 14564313
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 1800 mg/day in addition to HMG-CoA reductase inhibitor
Trial: 14564313
Drug: HMG-CoA reductase
RxNorm normalized name: HMG-CoA reductase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMG-CoA reductase inhibitor
Trial: 11091245
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of blood transfusion and subsequent development of infection
Trial: 26028361
Drug: 2.4 g
RxNorm normalized name: ZINC OXIDE 12.4 g in 100 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 g amino acids/(kg·d) plus 2 g lipids/(kg·d)
Trial: 26028361
Drug: 3.6 g
RxNorm normalized name: ALCOHOL 3.6 g EXTRACORPOREAL CLOTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.6 g amino acids/(kg·d) plus 2 g lipids/(kg·d)